267 related articles for article (PubMed ID: 16339682)
1. Pulmonary hypertension in beta-thalassemia.
Aessopos A; Farmakis D
Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682
[TBL] [Abstract][Full Text] [Related]
2. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.
Aessopos A; Farmakis D; Deftereos S; Tsironi M; Tassiopoulos S; Moyssakis I; Karagiorga M
Chest; 2005 May; 127(5):1523-30. PubMed ID: 15888823
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.
Karimi M; Borzouee M; Mehrabani A; Cohan N
Eur J Haematol; 2009 Mar; 82(3):213-8. PubMed ID: 19077048
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
[TBL] [Abstract][Full Text] [Related]
5. Heart failure in beta-thalassemia syndromes: a decade of progress.
Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
[TBL] [Abstract][Full Text] [Related]
6. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology.
Aessopos A; Kati M; Farmakis D
Haematologica; 2007 May; 92(5):658-65. PubMed ID: 17488690
[TBL] [Abstract][Full Text] [Related]
7. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
Farmakis D; Triposkiadis F; Lekakis J; Parissis J
Eur J Heart Fail; 2017 Apr; 19(4):479-489. PubMed ID: 28000341
[TBL] [Abstract][Full Text] [Related]
8. Cardiac involvement in thalassemia intermedia: a multicenter study.
Aessopos A; Farmakis D; Karagiorga M; Voskaridou E; Loutradi A; Hatziliami A; Joussef J; Rombos J; Loukopoulos D
Blood; 2001 Jun; 97(11):3411-6. PubMed ID: 11369631
[TBL] [Abstract][Full Text] [Related]
9. Cardiac involvement in beta-thalassemia major and beta-thalassemia intermedia.
Ferrara M; Matarese SM; Borrelli B; Perrotta A; Simeone G; Greco N; Iarussi D; Esposito L
Hemoglobin; 2004 May; 28(2):123-9. PubMed ID: 15182054
[TBL] [Abstract][Full Text] [Related]
10. Thalassemia intermedia today: should patients regularly receive transfusions?
Aessopos A; Kati M; Meletis J
Transfusion; 2007 May; 47(5):792-800. PubMed ID: 17465943
[TBL] [Abstract][Full Text] [Related]
11. Echocardiography in thalassemic patients on blood transfusions and chelation without heart failure.
Rodrigues A; Guimarães-Filho FV; Braga JC; Rodrigues CS; Waib P; Fabron-Junior A; Tan DM; França AC; Okoshi MP; Okoshi K
Arq Bras Cardiol; 2013 Jan; 100(1):75-81. PubMed ID: 23295250
[TBL] [Abstract][Full Text] [Related]
12. Cardiac status in well-treated patients with thalassemia major.
Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for pulmonary hypertension in patients with β thalassemia intermedia.
Karimi M; Musallam KM; Cappellini MD; Daar S; El-Beshlawy A; Belhoul K; Saned MS; Temraz S; Koussa S; Taher AT
Eur J Intern Med; 2011 Dec; 22(6):607-10. PubMed ID: 22075289
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
Mokhtar GM; Tantawy AA; Adly AA; Ismail EA
Hemoglobin; 2011; 35(4):382-405. PubMed ID: 21797705
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients.
Liguori C; Pitocco F; Di Giampietro I; De Vivo AE; Schena E; Giurazza F; Sorrentino F; Zobel BB
Biomed Res Int; 2015; 2015():857642. PubMed ID: 25922841
[TBL] [Abstract][Full Text] [Related]
16. Congestive heart failure and treatment in thalassemia major.
Aessopos A; Kati M; Tsironi M
Hemoglobin; 2008; 32(1-2):63-73. PubMed ID: 18274984
[TBL] [Abstract][Full Text] [Related]
17. Thalassemia intermedia is associated with a proatherogenic biochemical phenotype.
Lai ME; Vacquer S; Carta MP; Spiga A; Cocco P; Angius F; Mandas A; Dessì S
Blood Cells Mol Dis; 2011 Apr; 46(4):294-9. PubMed ID: 21402483
[TBL] [Abstract][Full Text] [Related]
18. Cardiac involvement in sickle beta-thalassemia.
Aessopos A; Farmakis D; Trompoukis C; Tsironi M; Moyssakis I; Tsaftarides P; Karagiorga M
Ann Hematol; 2009 Jun; 88(6):557-64. PubMed ID: 19107483
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major.
Mavrogeni S; Gotsis E; Ladis V; Berdousis E; Verganelakis D; Toulas P; Cokkinos DV
Int J Cardiovasc Imaging; 2008 Dec; 24(8):849-54. PubMed ID: 18581254
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function.
Hagar RW; Morris CR; Vichinsky EP
Br J Haematol; 2006 May; 133(4):433-5. PubMed ID: 16643452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
